Jane Street Group, LLC Brooklyn Immuno Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
BUY
$0.48 - $2.03 $3,307 - $13,988
6,891 Added 51.75%
20,208 $10,000
Q1 2022

May 17, 2022
SELL
$1.76 - $4.84 $37,806 - $103,968
-21,481 Reduced 61.73%
13,317 $27,000
Q4 2021

Feb 15, 2022
BUY
$4.17 - $9.79 $78,725 - $184,825
18,879 Added 118.59%
34,798 $145,000
Q3 2021

Nov 16, 2021
BUY
$8.86 - $17.05 $141,042 - $271,418
15,919 New
15,919 $148,000

Others Institutions Holding BTX

# of Institutions
1
Shares Held
1.21M
Call Options Held
0
Put Options Held
0
View Full List

About Brooklyn ImmunoTherapeutics, Inc.

BTX Quotes by TradingView
  • Ticker BTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,825,700
  • Description
  • Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...
More about BTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email